A5087171974- Obsessive-Compulsive Spectrum Disorders
- Transcranial Magnetic Stimulation Studies
- Parkinson's Disease Mechanisms and Treatments
- Neurological disorders and treatments
- Attention Deficit Hyperactivity Disorder
- Conducting polymers and applications
- Functional Brain Connectivity Studies
- Neural and Behavioral Psychology Studies
- Pain Management and Treatment
- Cancer, Hypoxia, and Metabolism
- Dye analysis and toxicity
- Cancer-related Molecular Pathways
- Botulinum Toxin and Related Neurological Disorders
- Personality Disorders and Psychopathology
- Mental Health Treatment and Access
- Cerebral Palsy and Movement Disorders
- Fibromyalgia and Chronic Fatigue Syndrome Research
- Sexual function and dysfunction studies
- Electrochemical Analysis and Applications
- Parkinson's Disease and Spinal Disorders
- Metabolism, Diabetes, and Cancer
- Balance, Gait, and Falls Prevention
- Nuclear Receptors and Signaling
- Stress Responses and Cortisol
- Adsorption and biosorption for pollutant removal
Shanghai Jiao Tong University
2021-2024
Ruijin Hospital
2021-2024
Shanghai Mental Health Center
2021-2022
Hamad bin Khalifa University
2020
North Carolina Central University
2015
First Affiliated Hospital of Henan University of Science and Technology
2015
Abstract Background Obsessive-compulsive disorder (OCD) can cause substantial damage to quality of life. Continuous theta burst stimulation (cTBS) is a promising treatment for OCD patients with the advantages safety and noninvasiveness. Objective The present study aimed evaluate efficacy cTBS over bilateral supplementary motor area (SMA) single-blind, sham-controlled design. Methods Fifty-four were randomized receive active or sham SMA 4 weeks (five sessions per week, 20 in total). Patients...
Postural abnormalities (PA) are common in the advanced stages of Parkinson's disease (PD), but effective therapies lacking. A few studies suggested that spinal cord stimulation (SCS) could be a potential therapy whereas its effect is still uncertain. We aimed to investigate whether SCS had for benefiting PD patients with PA.
Abstract The widely used toxic dye malachite green (MG) poses a significant risk to human health, having mutagenic effect. Waste date stones were produce microwave‐activated carbons and applied adsorb the highly dye. critically important task of selecting correct design adsorption capacity for different effluent pollutant concentrations meet discharge limit standards is described novel selection criteria approach presented.
Patients with Parkinson's disease (PD) and those multiple system atrophy (MSA) show similar symptoms but have different clinical treatments. It will be helpful to discriminate between these two kinds of patients at an early or middle stage. The purpose this study is highlight the differences in posturographic characterization PD MSA during quiet standing perturbed standing.A total clinically diagnosed 42 32 participated experiment. were asked first stand on a static balance force platform...
Due to a high degree of symptom overlap in the early stages, with movement disorders predominating, Parkinson's disease (PD) and multiple system atrophy (MSA) may exhibit similar decline motor areas, yet they differ their spread throughout brain, ultimately resulting two distinct diseases. Drawing upon neuroimaging analyses altered cortex excitability, potential diffusion mechanisms were delved into, comparisons correlations across groups conducted bid uncover significant pathological...
Background Brain network dysfunction has been characterized by resting-state electroencephalography (EEG) and magnetic resonance imaging (MRI) in the prodromal stage. This study aimed to identify multi-modal electrophysiological neuroimaging biomarkers for differential diagnosis synucleinopathies phenoconversion isolated rapid eye movement sleep behavior disorder (iRBD). Methods We enrolled 35 patients with multiple system atrophy (MSA), 32 Parkinson's disease (PD), 30 iRBD matched healthy...
As a typical high-disability neurodegenerative disease, Parkinson's disease (PD) progresses variably, and patients who are clinically insensitive to dopaminergic therapy whose symptoms fail improve commonly observed. result, achieving early neuron protection is critical.The NET-PD study 2-year prospective single-center, double-blind, multi-arm, delayed-start, sham-controlled clinical trial assessing the long-term neuroprotective effect of intermittent theta burst stimulation (iTBS) in PD...